Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

312 evidences · page 8 / 13

25,2 %Among 202 tuberculosis patients in the North Central zone of Nigeria, 51 (25.2%) showed resistance to at least one drug.

Nigeriatuberculosepublié 2019Journal of epidemiology and global healthPubMeddocument de 7 observations

14,8 %A proportion of males (14.8%) were more likely to show an understanding of the complementary association of HIV and TB than females (10.5%).

Nigeriatuberculose · VIH/sidapublié 2024BMC public healthPubMeddocument de 4 observations

18,6 %Thirty-eight (18.6%) of the TB patients relocated after 6 months of treatment.

Nigeriatuberculosepublié 2022Frontiers in cellular and infection microbiologyPubMeddocument de 15 observations

10,4 %Probable chronic pulmonary aspergillosis was 10.4% at baseline.

Nigeriapulmonary aspergillosis · tuberculosepublié 2022Frontiers in cellular and infection microbiologyPubMeddocument de 15 observations

25 %The WHO region of Africa accounted for 25% of people with TB globally in 2019.

Nigeriatuberculoseobservé 2019publié 2021International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument de 18 observations

36 casesAmong pulmonary TB patients with HIV co-morbidity, 36 (66.7%) were depressed compared to 35 (35.7%) without HIV co-morbidity.

Nigeriatuberculose · VIH/sidaobservé 2017publié 2020West African journal of medicinePubMeddocument de 7 observations

60,9 %At baseline, only 60.9% of TB patients scored 'good' or 'very good' quality of life and health on the WHOQOL-Bref.

Nigeriatuberculosepublié 2022Frontiers in cellular and infection microbiologyPubMeddocument de 15 observations

81,2 %The treatment success rate for tuberculosis patients under DOTS was 81.2% overall.

Nigeriatuberculoseobservé 2012-2016publié 2022African health sciencesPubMeddocument de 17 observations

82,5 %Majority of the respondents (500, 82.5%) had positive attitude toward tuberculosis.

Nigeriatuberculosepublié 2023African health sciencesPubMeddocument de 7 observations

1,677 AORParticipants who were virally suppressed had a higher likelihood of favorable TB treatment outcome compared to those who were virally unsuppressed (adjusted odds ratio = 1.677, 95% confidence interval = 1.036–2.716).

Nigeriatuberculose · VIH/sidapublié 2024The Pan African medical journalPubMeddocument de 5 observations

97,5 %SD Bioline MPT64 identified 117 MTBC isolates correctly, producing a sensitivity of 97.5% (95% CI, 92.9–99.2).

Nigeriatuberculosepublié 2021Journal of immunoassay & immunochemistryPubMeddocument de 6 observations

4,24 pointsThe least change in HRQoL was on the emotional well-being domain (mean change = 4.24, p=0.05).

Nigeriatuberculosepublié 2018Malawi medical journal : the journal of Medical Association of MalawiPubMeddocument de 6 observations

441 individuals_per_caseOn average, 441 individuals needed to be screened to diagnose 1 tuberculosis case.

Nigeriatuberculosepublié 2024Global health, science and practicePubMeddocument de 15 observations

72,1 %The diagnostic yield of stool GeneXpert alone was 72.1%.

Nigeriatuberculosepublié 2026BMC infectious diseasesPubMeddocument de 10 observations

6,4 %There were 221 presumptive tuberculosis cases (6.4%) among the screened diabetes mellitus patients.

Nigeriadiabète (non précisé) · tuberculosepublié 2020Advances in respiratory medicinePubMeddocument de 7 observations

75,3 %The annual mean measured successful treatment outcome was 75.3% (±8.8%).

Nigeriatuberculosepublié 2020PloS onePubMeddocument de 10 observations

4,21 AORPeople living with HIV in conflict zones in Nigeria were more than four times more likely to acquire TB than those from non-conflict zones, with an adjusted odds ratio of 4.21.

Nigeriatuberculoseobservé 2018publié 2025Tropical medicine & international health : TM & IHPubMeddocument de 7 observations

7,8 %Sixteen (7.8%) of the TB patients were lost to follow-up.

Nigeriatuberculosepublié 2022Frontiers in cellular and infection microbiologyPubMeddocument de 15 observations

55 %55% of the drug-resistant tuberculosis (DR-TB) group were male.

Nigeriatuberculosepublié 2024Journal of global antimicrobial resistancePubMeddocument de 8 observations

4,5 mmol/LA low total serum cholesterol (≤4.5 mmol/L) at baseline was associated with increased risk of tuberculosis in the SECOND-LINE trial.

Nigeriatuberculosepublié 2021Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 6 observations

29,7 %Of 425 suspected TB patients in Benue State, Nigeria, 126 (29.7%) yielded mycobacterial isolates.

Nigeriatuberculoseobservé July 2016 to February 2018publié 2020Ethiopian journal of health sciencesPubMeddocument de 10 observations

10 %The annual mean measured mortality was 10.0% (±3.6%).

Nigeriatuberculosepublié 2020PloS onePubMeddocument de 10 observations

85 %The national target treatment success rate for tuberculosis control is 85%.

Nigeriatuberculosepublié 2020Journal of infection and public healthPubMeddocument de 16 observations

TB incidence rates are five-to-fifty times higher among inmates in prison settings than the general population.

Nigeriatuberculosepublié 2022PloS onePubMeddocument de 11 observations

5,5 %One (5.5%) of the 18 patients with Mycobacterium tuberculosis (MTB) detection were diagnosed with diabetes mellitus (DM).

Nigeriadiabète (non précisé) · tuberculoseobservé 2017publié 2022West African journal of medicinePubMeddocument de 14 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.